Conformational Analysis of Free and Bound Retinoic Acid.

The conformational profiles of unbound all-trans and 9-cis retinoic acid (RA) have been determined using classical and quantum mechanical calculations. Sixty-six all-trans-RA (ATRA) and forty-eight 9-cis-RA energy minimum conformers were identified via HF/6-31G* geometry optimizations in vacuo. Their relative conformational energies were estimated utilizing the M06, M06-2x and MP2 methods combined with the 6-311+G(d,p), aug-cc-pVDZ and aug-cc-pVTZ basis sets, as well as complete basis set MP2 extrapolations using the latter two basis sets. Single-point energy calculations performed with the M06-2x density functional were found to yield similar results to MP2/CBS for the low-energy retinoic acid conformations. Not unexpectedly, the conformational propensities of retinoic acid were governed by the orientation and arrangement of the torsion angles associated with the polyene tail. We also used previously reported QM/MM X-ray refinement results on four ATRA-protein crystal structures plus one newly refined 9-cis-RA complex (PDB ID 1XDK) in order to investigate the conformational preferences of bound retinoic acid. In the re-refined RA conformers the conjugated double bonds are nearly coplanar, which is consistent with the global minimum identified by the Omega/QM method rather than the corresponding crystallographically determined conformations given in the PDB. Consequently, a 91.3% average reduction of the local strain energy in the gas phase, as well as 92.1% in PCM solvent, was observed using the QM/MM refined structures versus the PDB deposited RA conformations. These results thus demonstrate that our QM/MM X-ray refinement approach can significantly enhance the quality of X-ray crystal structures refined by conventional refinement protocols, thereby providing reliable drug-target structural information for use in structure-based drug discovery applications.

[1]  U. Ryde,et al.  The protonation status of compound II in myoglobin, studied by a combination of experimental data and quantum chemical calculations: quantum refinement. , 2004, Biophysical journal.

[2]  C. Bloomfield,et al.  All-trans-retinoic acid in acute promyelocytic leukemia. , 1997, The New England journal of medicine.

[3]  Kenneth M Merz,et al.  QM/MM X-ray refinement of zinc metalloenzymes. , 2010, Journal of inorganic biochemistry.

[4]  H P Koeffler,et al.  Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Satoru Miyano,et al.  Open source clustering software , 2004 .

[6]  K. White,et al.  Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer , 2009, Cell.

[7]  T. Kakitani,et al.  Comprehensive study of molecular conformation and adiabatic potential surface of all-trans retinal by the CNDO/2 method , 1990 .

[8]  Lucia Altucci,et al.  Design of selective nuclear receptor modulators: RAR and RXR as a case study , 2007, Nature Reviews Drug Discovery.

[9]  A. Dalgleish,et al.  Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-γ and altered expression of Bcl-2/Bax , 2002, British Journal of Cancer.

[10]  E. Dmitrovsky,et al.  Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.

[11]  Peter Gruss,et al.  Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid , 1991, Cell.

[12]  B. Shroot,et al.  Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. , 1995, Journal of medicinal chemistry.

[13]  G. Krupitza,et al.  Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcription. , 1993, British Journal of Cancer.

[14]  W. Hendrickson Stereochemically restrained refinement of macromolecular structures. , 1985, Methods in enzymology.

[15]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[16]  W. Thiel,et al.  Quantum refinement of protein structures: implementation and application to the red fluorescent protein DsRed.M1. , 2010, The journal of physical chemistry. B.

[17]  Ulf Ryde,et al.  Quantum refinement of [FeFe] hydrogenase indicates a dithiomethylamine ligand. , 2010, Journal of the American Chemical Society.

[18]  Alok J. Saldanha,et al.  Java Treeview - extensible visualization of microarray data , 2004, Bioinform..

[19]  P. Fernhoff,et al.  Retinoic acid embryopathy. , 1985, The New England journal of medicine.

[20]  Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target. , 2004, Journal of medicinal chemistry.

[21]  Babak Borhan,et al.  Structural analysis of site-directed mutants of cellular retinoic acid-binding protein II addresses the relationship between structural integrity and ligand binding. , 2008, Acta crystallographica. Section D, Biological crystallography.

[22]  C. Glass,et al.  Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators , 1998, Nature.

[23]  Kristina Nilsson,et al.  Protonation status of metal-bound ligands can be determined by quantum refinement. , 2004, Journal of inorganic biochemistry.

[24]  Xue Li,et al.  QM/MM refinement and analysis of protein bound retinoic acid , 2012, J. Comput. Chem..

[25]  T. A. Jones,et al.  Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid. , 1995, Structure.

[26]  W. Bollag Arotinoids. A new class of retinoids with activities in oncology and dermatology. , 1981, Cancer chemotherapy and pharmacology.

[27]  Kenneth M Merz,et al.  Refinement of protein crystal structures using energy restraints derived from linear-scaling quantum mechanics. , 2005, Acta crystallographica. Section D, Biological crystallography.

[28]  H. Gronemeyer,et al.  Characterization of the Interaction between Retinoic Acid Receptor/Retinoid X Receptor (RAR/RXR) Heterodimers and Transcriptional Coactivators through Structural and Fluorescence Anisotropy Studies* , 2005, Journal of Biological Chemistry.

[29]  Ilme Schlichting,et al.  Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1. , 2008, Biochemistry.

[30]  L. Gudas,et al.  Retinoids, retinoic acid receptors, and cancer. , 2011, Annual review of pathology.

[31]  Ulf Ryde,et al.  Identification of the peroxy adduct in multicopper oxidases by a combination of computational chemistry and extended X-ray absorption fine-structure measurements. , 2007, Journal of the American Chemical Society.

[32]  Maria Carmo-Fonseca,et al.  Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells , 1994, Cell.

[33]  J. Karle,et al.  Crystal Structure of the Visual Chromophores, 11-cis and all-trans Retinal , 1971, Nature.

[34]  W. Miller The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer , 1998, Cancer.

[35]  Kristina Nilsson,et al.  Quantum chemical geometry optimizations in proteins using crystallographic raw data , 2002, J. Comput. Chem..

[36]  Xiao He,et al.  Conformational variability of benzamidinium-based inhibitors. , 2009, Journal of the American Chemical Society.

[37]  K. Merz,et al.  Further analysis and comparative study of intermolecular interactions using dimers from the S22 database. , 2009, The Journal of chemical physics.

[38]  Xue Li,et al.  Accurate assessment of the strain energy in a protein‐bound drug using QM/MM X‐ray refinement and converged quantum chemistry , 2011, J. Comput. Chem..

[39]  Conformational analysis of retinoids and restriction of their dynamics by retinoid-binding proteins. , 1996, The Biochemical journal.

[40]  M. Gottardis,et al.  Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand. , 1996, Cancer research.

[41]  M. Sporn,et al.  Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. , 1994, Cancer research.

[42]  P. Wade,et al.  Cancer biology and NuRD: a multifaceted chromatin remodelling complex , 2011, Nature Reviews Cancer.

[43]  Michael Levitt,et al.  Refinement of Large Structures by Simultaneous Minimization of Energy and R Factor , 1978 .

[44]  Kenneth M Merz,et al.  Critical assessment of quantum mechanics based energy restraints in protein crystal structure refinement , 2006, Protein science : a publication of the Protein Society.

[45]  H. Yoshiji,et al.  Inhibition by N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid of exogenous and endogenous development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in the livers of rats. , 1997, Carcinogenesis.

[46]  Jean-Paul Renaud,et al.  Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.

[47]  Kenneth M Merz,et al.  Assigning the protonation states of the key aspartates in β-Secretase using QM/MM X-ray structure refinement. , 2006, Journal of chemical theory and computation.

[48]  Kristina Nilsson,et al.  Quantum chemistry can locally improve protein crystal structures. , 2003, Journal of the American Chemical Society.

[49]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.